Global WholeHealth Partners Corporation (GWHP)
USD 0.0
(-90.0%)
USD 0.0
(-90.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | - USD | -100.0% |
| 2022 | 4.07 Million USD | 18.87% |
| 2021 | 3.42 Million USD | -21.35% |
| 2020 | 4.35 Million USD | 12716.64% |
| 2019 | 33.99 Thousand USD | 2732.67% |
| 2018 | 1200.00 USD | 458.14% |
| 2017 | 215.00 USD | 0.0% |
| 2014 | 95.06 Thousand USD | -7.93% |
| 2013 | 103.25 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 FY | - USD | -100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2022 Q2 | 1.87 Million USD | 55.9% |
| 2022 Q1 | 1.2 Million USD | 136.7% |
| 2022 FY | 4.07 Million USD | 18.87% |
| 2022 Q4 | 81.72 Thousand USD | -90.99% |
| 2022 Q3 | 906.64 Thousand USD | -51.76% |
| 2021 FY | 3.42 Million USD | -21.35% |
| 2021 Q3 | 2.61 Million USD | 2515.38% |
| 2021 Q4 | 509.31 Thousand USD | -80.5% |
| 2021 Q2 | 99.84 Thousand USD | -51.54% |
| 2021 Q1 | 206.04 Thousand USD | -94.62% |
| 2020 FY | 4.35 Million USD | 12716.64% |
| 2020 Q4 | 3.83 Million USD | 741.36% |
| 2020 Q2 | 51.09 Thousand USD | 171.83% |
| 2020 Q1 | 18.79 Thousand USD | -22.91% |
| 2020 Q3 | 455.37 Thousand USD | 791.19% |
| 2019 Q4 | 24.38 Thousand USD | 170.69% |
| 2019 FY | 33.99 Thousand USD | 2732.67% |
| 2019 Q2 | 300.00 USD | -75.0% |
| 2019 Q1 | 1200.00 USD | 0.0% |
| 2019 Q3 | 9008.00 USD | 2902.67% |
| 2018 FY | 1200.00 USD | 458.14% |
| 2017 FY | 215.00 USD | 0.0% |
| 2015 Q3 | 1770.00 USD | -96.22% |
| 2015 Q1 | 122.48 Thousand USD | 120.93% |
| 2015 Q2 | 46.86 Thousand USD | -61.74% |
| 2014 Q1 | 31.12 Thousand USD | -9.58% |
| 2014 Q4 | 55.43 Thousand USD | 939.94% |
| 2014 Q3 | 5331.00 USD | 67.75% |
| 2014 Q2 | 3178.00 USD | -89.79% |
| 2014 FY | 95.06 Thousand USD | -7.93% |
| 2013 Q4 | 34.41 Thousand USD | 382333.33% |
| 2013 FY | 103.25 Thousand USD | 0.0% |
| 2013 Q3 | 9.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | 100.0% |
| Arrayit Corporation | 6.19 Million USD | 100.0% |
| Atlantic International Corp. | 5.57 Million USD | 100.0% |
| Biocept, Inc. | 29.4 Million USD | 100.0% |
| Bioqual, Inc. | 7.44 Million USD | 100.0% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | 100.0% |
| DermTech, Inc. | 104.01 Million USD | 100.0% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 100.0% |
| iMD Companies, Inc. | 151.8 Thousand USD | 100.0% |
| IDenta Corp. | 662.97 Thousand USD | 100.0% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | 100.0% |
| InVitro International | 661.32 Thousand USD | 100.0% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | 100.0% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | 100.0% |
| Medical Imaging Corp. | 1.91 Million USD | 100.0% |
| NovelStem International Corp. | 3.53 Million USD | 100.0% |
| Optigenex Inc. | 1.28 Million USD | 100.0% |
| PharmChem, Inc. | 2.93 Million USD | 100.0% |
| Proteome Sciences plc | 3.26 Million USD | 100.0% |
| Response Genetics, Inc | 25.31 Million USD | 100.0% |
| Rennova Health, Inc. | 7.67 Million USD | 100.0% |
| RushNet, Inc. | 1.78 Million USD | 100.0% |
| ScreenPro Security Inc. | 3.23 Million USD | 100.0% |
| Stella Diagnostics Inc. | 11.42 Million USD | 100.0% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | 100.0% |
| Todos Medical Ltd. | 14.05 Million USD | 100.0% |